Małgorzata Bilińska

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

James F. Howard, Vera Bril, Ted M. Burns et al. · Neurology · 2019 · 268 citations · Full text

Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis

Anna Pokryszko‐Dragan, Irena Frydecka, Agata Kosmaczewska et al. · Clinical Neurology and Neurosurgery · 2012 · 65 citations

Clinical Disorders, Psychoneuroimmunology, Neurobiology Of Disease +11

Sleep disturbances in patients with multiple sclerosis

Anna Pokryszko‐Dragan, Małgorzata Bilińska, Ewa Gruszka et al. · Neurological Sciences · 2012 · 61 citations · Full text

Sleep Medicine, Sleep Disorders, Sleep +13

Event-related potentials and cognitive performance in multiple sclerosis patients with fatigue

Anna Pokryszko‐Dragan, Mieszko Zagrajek, Krzysztof Słotwiński et al. · Neurological Sciences · 2016 · 50 citations · Full text